Izrael -
hebrejščina -
Ministry of Health
דסטיניב תרו 70 מג
taro international ltd, israel - dasatinib - טבליות מצופות פילם - dasatinib 70 mg - dasatinib
Izrael -
hebrejščina -
Ministry of Health
דסטיניב תרו 80 מג
taro international ltd, israel - dasatinib - טבליות מצופות פילם - dasatinib 80 mg - dasatinib
Izrael -
hebrejščina -
Ministry of Health
דסטיניב טבע 100 מג
teva israel ltd - dasatinib as monohydrate - טבליות מצופות פילם - dasatinib as monohydrate 100 mg - dasatinib
Izrael -
hebrejščina -
Ministry of Health
דסטיניב טבע 20 מג
teva israel ltd - dasatinib as monohydrate - טבליות מצופות פילם - dasatinib as monohydrate 20 mg - dasatinib
Izrael -
hebrejščina -
Ministry of Health
דסטיניב טבע 50 מג
teva israel ltd - dasatinib as monohydrate - טבליות מצופות פילם - dasatinib as monohydrate 50 mg - dasatinib
Izrael -
hebrejščina -
Ministry of Health
דסטיניב טבע 70 מג
teva israel ltd - dasatinib as monohydrate - טבליות מצופות פילם - dasatinib as monohydrate 70 mg - dasatinib
Izrael -
hebrejščina -
Ministry of Health
סוטנט 12.5 מג
pfizer pharmaceuticals israel ltd - sunitinib as malate - קפסולות - sunitinib as malate 12.5 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
Izrael -
hebrejščina -
Ministry of Health
סוטנט 25 מג
pfizer pharmaceuticals israel ltd - sunitinib as malate - קפסולות - sunitinib as malate 25 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
Izrael -
hebrejščina -
Ministry of Health
סוטנט 50 מג
pfizer pharmaceuticals israel ltd - sunitinib as malate - קפסולות - sunitinib as malate 50 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
Izrael -
hebrejščina -
Ministry of Health
טסיגנה 200 מג
novartis israel ltd - nilotinib as monohydrate - קפסולות - nilotinib as monohydrate 200 mg - nilotinib - nilotinib - treatment of philadelphia chromosome positive chronic myeloid leukaemia (ph+ cml) in chronic or accelerated phase in patients resistant to or experiencing significant toxicity during treatment with imatinib.treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.